Skip to content

EV / EBITDA at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
8.6×-2.0×
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
-2.9×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Brookdale Senior Living logo
Brookdale Senior LivingBKD
21.7×+6.6×
Astrana Health logo
Astrana HealthASTH
13.8×-0.8×
HCA Healthcare logo
HCA HealthcareHCA
9.9×+0.6×

Other financials

Income statement

See full
Revenue$363.6M+7.7%
Gross profit$107.7M+22.1%
Operating income$30.5M+29.1%
Net income$25.1M+18.1%
EPS (diluted)$1.16+19.6%

Balance sheet

See full
Cash & equivalents$103.1M+6.3%
Total debt$138.7M-44.7%
Total equity$1.1B+12.1%
Total assets$1.4B+2.0%

Cash flow

See full
Operating cash flow$52.4M+176%
CapEx$1.7M-9.1%
Free cash flow$50.7M+197%

Valuation

See full
Market cap$1.81B-2.8%

Profitability

See full
Gross margin32.6%+0.4pp
Operating margin9%+0.2pp
Net margin6.9%+0.4pp
FCF margin9.5%+2.0pp

Returns & leverage

See full
Return on equity9.4%+0.3pp
Debt / equity0.1×-0.1×
Current ratio1.8×+0.1×

Where this comes from

Calculated from Addus HomeCare’s reported figures.

Based on the most recent quarter.

The official record: Addus HomeCare’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Addus HomeCare's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Addus HomeCare's EV / EBITDA?
Addus HomeCare (ADUS) reported EV / EBITDA of 15.8× in Q1 2025.
How has Addus HomeCare's EV / EBITDA changed year-over-year?
Addus HomeCare's EV / EBITDA increased by 0.4% year-over-year, from 15.7× to 15.8×.
What is the long-term trend for Addus HomeCare's EV / EBITDA?
Over 4 years (2020 to 2024), Addus HomeCare's EV / EBITDA has grown at a -11.4% compound annual growth rate (CAGR), from 34.2× to 21.1×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.